Is Ozempic the Gateway Drug for CBT?
Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.
A Pathway Out of Addiction?
Could a wearable ultrasound device be a pathway out of addiction, or even a way to prevent it?
Testing Advances on Psychedelic Therapies for Substance Use Disorders
Positive results have caused a surge in clinical trials of psychedelic substances to treat substance use disorders.
The Brain Scans of Adolescents Show Damage Caused by Internet Addiction
A systematic review of the brain scans of adolescents with internet addiction found surprising results.
BrainWeighve Eating Addiction Telehealth App Expands UCLA Trial
Telehealth provider, eHealth International, expands their UCLA trial of weight loss app, BrainWeighve.
Ozempic Maker to Study Its Effect on Alcohol Consumption
Novo Nordisk, the maker of Ozempic, plans to study the drug’s effect on alcohol consumption.